GlassScriptPhysician profile
Devin Nitin Patel
NPI 1437505559
$10,559.22
in general payments reported to CMS, 2019-2025
32 companies · $3,056 in 2025
The $3,056 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $75.83 · 2021: $1,609 · 2022: $1,025 · 2023: $922 · 2024: $3,639 · 2025: $3,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $1,621 · Food and Beverage: $976 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $19.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $1,621.29 |
| Food and Beverage | $975.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $19.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,920.40 | 2021-2025 | Da Vinci Surgical System |
| Janssen Scientific Affairs, LLC | $1,010.00 | 2021 | |
| Boston Scientific Corporation | $386.70 | 2019-2022 | |
| Janssen Biotech, INC. | $266.60 | 2021-2023 | Erleada |
| Abbvie INC. | $217.46 | 2022-2024 | |
| Astellas Pharma US INC | $206.59 | 2022-2023 | Myrbetriq, Xtandi |
| Urogen Pharma, INC. | $171.89 | 2022 | |
| Stryker Corporation | $158.40 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.54 | 2021-2023 | |
| Pfizer INC. | $126.34 | 2021-2023 | |
| Verity Pharmaceuticals INC. | $90.39 | 2022-2023 | Trelstar |
| Myovant Sciences INC. | $89.21 | 2022 | |
| Merck Sharp & Dohme LLC | $80.17 | 2022-2023 | Welireg, Keytruda, Lynparza |
| Amgen INC. | $78.87 | 2022 | |
| Sumitomo Pharma America, INC. | $69.70 | 2023 | Gemtesa, Orgovyx |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $67.10 | 2021 | |
| Genentech, INC. | $57.41 | 2020 | |
| Teleflex LLC | $55.00 | 2021 | |
| Angiodynamics, INC. | $53.58 | 2021-2023 | Nanoknife |
| Ferring Pharmaceuticals INC. | $48.19 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $39.50 | 2022-2023 | Pylarify |
| Novartis Pharmaceuticals Corporation | $26.00 | 2025 | |
| Clarus Therapeutics INC. | $24.30 | 2021 | |
| Accord Healthcare, INC. | $23.81 | 2022 | |
| Sun Pharmaceutical Industries INC. | $23.75 | 2023 | Yonsa |
| Tolmar Pharmaceuticals, INC. | $20.48 | 2021 | |
| 180 Medical, INC. | $19.99 | 2022 | |
| Novo Nordisk INC | $19.61 | 2023 | Wegovy, Saxenda |
| Procept Biorobotics Corporation | $18.42 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.97 | 2023 | Lynparza |
| Endo Pharmaceuticals INC. | $14.51 | 2023 | Xiaflex, Edex, Aveed |
| Myriad Genetic Laboratories, INC. | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.